McKittrick Justine M, Burke Thomas W, Petzold Elizabeth, Sempowski Gregory D, Denny Thomas N, Polage Christopher R, Tsalik Ephraim L, McClain Micah T
Duke University School of Medicine Durham North Carolina USA.
Center for Applied Genomics and Precision Medicine Duke University Durham North Carolina USA.
Health Sci Rep. 2022 Jul 22;5(4):e554. doi: 10.1002/hsr2.554. eCollection 2022 Jul.
Several cases of symptomatic reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after full recovery from a prior episode have been reported. As reinfection has become an increasingly common phenomenon, an improved understanding of the risk factors for reinfection and the character and duration of the serological responses to infection and vaccination is critical for managing the coronavirus disease 2019 (COVID-19) pandemic.
We described four cases of SARS-CoV-2 reinfection in individuals representing a spectrum of healthy and immunocompromised states, including (1) a healthy 41-year-old pediatrician, (2) an immunocompromised 31-year-old with granulomatosis with polyangiitis, (3) a healthy 26-year-old pregnant woman, and (4) a 50-year-old with hypertension and hyperlipidemia. We performed confirmatory quantitative reverse transcription-polymerase chain reaction and qualitative immunoglobulin M and quantitative IgG testing on all available patient samples to confirm the presence of infection and serological response to infection.
Our analysis showed that patients 1 and 2, a healthy and an immunocompromised patient, both failed to mount a robust serologic response to the initial infection. In contrast, patients 3 and 4, with minimal comorbid disease, both mounted a strong serological response to their initial infection, but were still susceptible to reinfection.
Repeat episodes of COVID-19 are capable of occurring in patients regardless of the presence of known risk factors for infection or level of serological response to infection, although this did not trigger critical illness in any instance.
已有报告称,数例患者在先前感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)完全康复后出现有症状的再次感染。由于再次感染已成为越来越常见的现象,更好地了解再次感染的风险因素以及对感染和疫苗接种的血清学反应的特征和持续时间,对于管理2019冠状病毒病(COVID-19)大流行至关重要。
我们描述了4例SARS-CoV-2再次感染病例,这些病例代表了一系列健康和免疫功能低下状态的个体,包括(1)一名健康的41岁儿科医生,(2)一名患有肉芽肿性多血管炎的31岁免疫功能低下者,(3)一名健康的26岁孕妇,以及(4)一名患有高血压和高脂血症的50岁患者。我们对所有可用的患者样本进行了验证性定量逆转录-聚合酶链反应以及定性免疫球蛋白M和定量IgG检测,以确认感染的存在以及对感染的血清学反应。
我们的分析表明,病例1和病例2,即一名健康患者和一名免疫功能低下患者,对初次感染均未产生强烈的血清学反应。相比之下,病例3和病例4合并症极少,对初次感染均产生了强烈的血清学反应,但仍易再次感染。
COVID-19患者能够再次发病,无论是否存在已知的感染风险因素或对感染的血清学反应水平如何,尽管在任何情况下这都未引发危重症。